-
Rachel Haurwitz, CEO of the Doudna lab spin-out, discusses the first CRISPR company’s clinical journey into allogeneic cell therapies, developed with proprietary genome-editing technology https://t.co/CdkK8R6nUr
— SynBioBeta (@SynBioBeta) June 18, 2023 -
It’s where the rich store their critical documents, obviously. https://t.co/MOR1agh4bP
— Rob Carlson (@rob_carlson) June 18, 2023 -
Thread.
— Rob Carlson (@rob_carlson) June 18, 2023
Moar beavers, please. https://t.co/bXh9vP4iuD -
Google Bard is coming up with new biology: https://t.co/dswnq890uN
— Mike White (@genologos) June 17, 2023 -
SCiFi Foods on cultivated meat unit economics: ‘We can make a blended product commercially viable without needing crazy-scale bioreactors’ https://t.co/0LANRzA8BU
— SynBioBeta (@SynBioBeta) June 17, 2023
Synthetic Biology